News
Novacea to Host Conference Call to Second Quarter Financial Results & Development Update
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-August 7, 2007 - Novacea, Inc.(Nasdaq:NOVC), announced today that the company will hold a conference call on August 14, 2007, to discuss its second quarter financial results.
The conference call will be held on Tuesday, August 14, 2007 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
This call is being webcast by Thomson/CCBN and can be accessed at Novacea's Web site at www.novacea.com.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (www.streetevents.com), a password-protected event management site.
About Novacea
Novacea, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing novel cancer therapies. Novacea has two product candidates in clinical trials, including Asentar(TM), which currently is in a Phase 3 clinical trial for androgen-independent prostate cancer, or AIPC. Novacea's second product candidate, AQ4N, is a hypoxia-activated prodrug that is currently in a Phase 1b/2a clinical trial in glioblastoma multiforme. More information on any of Novacea's trials can be found at www.ClinicalTrials.gov.
